Occupation: non-healthcare professional.(b)(4).Investigation evaluation: a product evaluation was not performed in response to this report because the product said to be involved was not provided to cook for evaluation.The report could not be confirmed.The lot number of the product said to be involved was used to review the device history record.A discrepancy or anomaly was not observed with the product that was released for distribution.Investigation conclusion: we could not conduct a complete investigation because the product said to be involved was not returned for evaluation.A definitive cause for the reported observation could not be determined.The size of tissue sample or biopsy to be excised can be controlled by how the user handles the forceps.If excessive pressure was applied during advancement into the tissue or during handle manipulation, this could have contributed to the reported observation.The instructions for use (ifu) direct the user: ¿advance forceps to biopsy or retrieval site, then open cups and advance into tissue to be biopsied or objected to be retrieved.Using slight pressure on handle, close forceps around tissue or object.Maintain gentle handle pressure to keep cups closed and gently withdraw forceps from site.¿ the ifu warns: "these single-use biopsy forceps should only be used to biopsy tissue where possible bleeding or hemorrhage will not present a danger for patients.Adequate plans for management of potential bleeding or hemorrhage and appropriate airway management should be in place." the ifu lists potential complications as: "those associated with gastrointestinal endoscopy include but are not limited to: perforation, bleeding or hemorrhage, aspiration, fever, infection, allergic reaction to medication, hypotension, respiratory depression or arrest, cardiac arrhythmia or arrest." prior to distribution, all captura pro biopsy forceps with spike forceps are subjected to a visual inspection to ensure device integrity.A review of the device history record confirmed that the lot said to be involved met all manufacturing requirements prior to shipment.Corrective action: a review of the complaint history was conducted and this represents an isolated occurrence.The likelihood of occurrence is considered rare.Corrective action is not warranted at this time based on the quality engineering risk assessment.Quality assurance will continue to monitor for complaint trends and reassess the risk assessment results as post market feedback continues to become available.
|
During upper gastrointestinal biopsy procedures, the physician used at least two (2) captura pro biopsy forceps with spike.The customer was concerned with the amount of "bite" taken in the biopsy and feels that it was causing more bleeding than it should and was requiring clipping that should not be required.Additional information provided by the cook district manager on 06-feb-2019: all cases were upper gastrointestinal cases, esophageal (from top to bottom) and gastric biopsies.No additional procedures were required due to these events, but additional clips were being used beyond what customer expects to have to use.A section of the devices did not remain inside the patients' body.The patients required more than expected hemostasis clipping due to this occurrence.According to the initial reporter, the patient did not experience any adverse effects due to this occurrence.
|